HomeCompareCRMX vs KMB

CRMX vs KMB: Dividend Comparison 2026

CRMX yields 22.08% · KMB yields 5.25%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CRMX wins by $37.0K in total portfolio value
10 years
CRMX
CRMX
● Live price
22.08%
Share price
$9.06
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$82.9K
Annual income
$8,360.71
Full CRMX calculator →
KMB
KMB
● Live price
5.25%
Share price
$96.47
Annual div
$5.06
5Y div CAGR
17%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$45.9K
Annual income
$5,211.33
Full KMB calculator →

Portfolio growth — CRMX vs KMB

📍 CRMX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCRMXKMB
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CRMX + KMB cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CRMX pays
KMB pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CRMX
Annual income on $10K today (after 15% tax)
$1,876.38/yr
After 10yr DRIP, annual income (after tax)
$7,106.60/yr
KMB
Annual income on $10K today (after 15% tax)
$445.84/yr
After 10yr DRIP, annual income (after tax)
$4,429.63/yr
At 15% tax rate, CRMX beats the other by $2,676.97/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CRMX + KMB for your $10,000?

CRMX: 50%KMB: 50%
100% KMB50/50100% CRMX
Portfolio after 10yr
$64.4K
Annual income
$6,786.02/yr
Blended yield
10.54%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on KMB right now

CRMX
No analyst data
KMB
Analyst Ratings
9
Buy
19
Hold
3
Sell
Consensus: Hold
Price Target
$123.00
+27.5% upside vs current
Range: $102.00 — $162.00
Altman Z
3.4
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CRMX buys
0
KMB buys
0
No recent congressional trades found for CRMX or KMB in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCRMXKMB
Forward yield22.08%5.25%
Annual dividend / share$2.00$5.06
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%17%
Portfolio after 10y$82.9K$45.9K
Annual income after 10y$8,360.71$5,211.33
Total dividends collected$49.5K$21.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: CRMX vs KMB ($10,000, DRIP)

YearCRMX PortfolioCRMX Income/yrKMB PortfolioKMB Income/yrGap
1← crossover$12,908$2,207.51$11,314$613.68+$1.6KCRMX
2$16,474$2,662.93$12,865$759.19+$3.6KCRMX
3$20,804$3,176.38$14,709$943.96+$6.1KCRMX
4$26,009$3,748.76$16,919$1,180.17+$9.1KCRMX
5$32,209$4,380.08$19,588$1,484.33+$12.6KCRMX
6$39,533$5,069.47$22,838$1,879.06+$16.7KCRMX
7$48,116$5,815.17$26,832$2,395.60+$21.3KCRMX
8$58,099$6,614.60$31,788$3,077.63+$26.3KCRMX
9$69,630$7,464.43$38,000$3,986.82+$31.6KCRMX
10$82,865$8,360.71$45,872$5,211.33+$37.0KCRMX

CRMX vs KMB: Complete Analysis 2026

CRMXStock

CRMX is a short-term tactical tool that aims to deliver twice (200%) the daily performance of Critical Metals Corp. (CRML), before fees and expenses. The fund primarily enters into total return swap agreements with major global financial institutions that mirror CRMLs daily returns. In case swaps are unavailable or less efficient, the fund may use FLEX call options or directly hold CRML stock. Purchasers holding shares for longer than a day will need to monitor and rebalance their position frequently to attempt to achieve the 2x multiple. Purchasers should conduct their own individual stock research prior to initiating a position and trade with conviction. Due to the complexities of the product, shares tend to perform as anticipated only when the underlying shares are trending, and holders are on the positive corresponding side of that trade. The remaining cash is invested in collaterals such as US Treasuries, money market funds, or short-term corporate debt.

Full CRMX Calculator →

KMBConsumer Staples

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products worldwide. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The Personal Care segment offers disposable diapers, swimpants, training and youth pants, baby wipes, feminine and incontinence care products, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Depend, Plenitud, Softex, Poise, and other brand names. The Consumer Tissue segment provides facial and bathroom tissues, paper towels, napkins, and related products under the Kleenex, Scott, Cottonelle, Viva, Andrex, Scottex, Neve, and other brand names. The K-C Professional segment offers wipers, tissues, towels, apparel, soaps, and sanitizers under the Kleenex, Scott, WypAll, Kimtech, and KleenGuard brands. The company sells household use products directly to supermarkets, mass merchandisers, drugstores, warehouse clubs, variety and department stores, and other retail outlets, as well as through other distributors and e-commerce; and away-from-home use products directly to manufacturing, lodging, office building, food service, and public facilities, as well as through distributors and e-commerce. Kimberly-Clark Corporation was founded in 1872 and is headquartered in Dallas, Texas.

Full KMB Calculator →
📬

Get this CRMX vs KMB comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CRMX vs SCHDCRMX vs JEPICRMX vs OCRMX vs KOCRMX vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.